Johnson & Johnson (XSGO:JNJ) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSGO:JNJ Johnson & Johnson XSGO:JNJ
88 GF Score
Price $254.79
GF Value $196.13
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Johnson & Johnson Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XSGO:JNJ
88GF Score
Johnson & Johnson XSGO:JNJ
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Johnson & Johnson (XSGO:JNJ) Overvalued in 2026?

Based on GuruFocus' analysis, Johnson & Johnson stock appears to be overvalued. The current stock price of $254.79 is trading 29.9% above its estimated GF Value™ of $196.13. GuruFocus considers Johnson & Johnson to be Modestly Overvalued.

Key valuation signals for XSGO:JNJ:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $196.13 vs. price of $254.79 (29.9% above fair value)
  • GF Score™: 88/100 with 7 warning signs

No single metric tells the full story. See the XSGO:JNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Johnson & Johnson Business Description

Address One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
88GF Score

Get the complete analysis for XSGO:JNJ

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$254.79
Price
$196.13
GF Value